Dupilumab was more effective in the treatment of pediatric AD than methotrexate or cyclosporine, regardless of skin color or race.

Deucravacitinib treatment yields sustained improvements in joint symptoms and skin disease severity among patients with active psoriatic arthritis.

The FDA has approved Ilumya (tildrakizumab-asmn) for active psoriatic arthritis in adults based on findings from the phase 3 INSPIRE-1 and INSPIRE-2 trials.

An etiology-based approach to the management of IGD should be used, although more research is needed to further guide clinical decision-making.

For patients with stage 3 CKD, fruits and vegetables were associated with better clinical outcomes than standard treatment or usual care.

Parents and caregivers should stop serving Once Upon a Farm Tractor Wheels toddler bars right away because they could cause deadly choking.

Maternal AD is associated with increased risk for some obstetric and neonatal adverse events, such as pre-eclampsia and Staphylococcal septicemia.

Premature menopause (younger than 40 years) was associated with greater risks for CVD and coronary heart disease compared with menopause at age 45 years or older.

HealthDay News — For pediatric patients with high-risk B-cell acute lymphoblastic leukemia (B-ALL), residential fine particulate matter (PM 2.5) concentrations during induction therapy are associated ...

The FDA granted Priority Review to Qtorin (rapamycin) 3.9% topical gel for microcystic lymphatic malformations, setting a PDUFA action date of Feb 28, 2027.

Dermatology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

In an update to the ongoing legal action against the Department of Education, a third judge ruled against the department, citing the decision as “exceeding its authority.” A third federal judge has ...